CPMD · Cannapharmarx, Inc. · Executive Compensation
$0.00
At close · Oct 20
View the 10-K filed Mar 31, 2026
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on current financial projections, the Company does not have sufficient existing cash resources to fund its current operations. Accordingly, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 18, 2026
Customer concentration
— top customer 63% of revenue
One customer — 63% of revenue (the year ended December 31, 2025)
“During the year ended December 31, 2025, the Company also recognized revenue of $861,476 (2024 - $nil) from the sale of cannabis products to a pharmaceutical company based in Germany. This comprised 63% of the revenues generated during the year ended December 31, 2025.”
One customer — 29% of revenue (the year ended December 31, 2025)
“During the year ended December 31, 2025, the Company recognized revenue of $394,633 (2024 - $770,265) from Cantek (Note 12), which was 29% of the total revenue (2024 - 94%).”
Market Cap
$1.42M
Shares
708.69M
Volume · Oct 20
5900
Avg daily vol (3M)
67.59K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Dominic Colvin | CEO | $64,038 |
| Gary Herick | CFO, Secretary | $56,500 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Gary Herick | CFO, Secretary | $199,300 |
| Dominic Colvin | CEO | $27,500 |
| Jim Samuelson | — | $27,500 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Rick Orman | member of the Board | Resigned | 2026-01-13 |
| Elliot Zemel | Board of Directors | Appointed | 2025-03-31 |
| Constantine Nkafu | Board of Directors | Appointed | 2025-03-31 |
| Constantine Nkafu | interim CEO | Appointed | 2025-03-31 |
| Oliver Foeste | Chief Financial Officer | Appointed | 2023-10-13 |
| Anthony Michael Panek | member of the Board | Appointed | 2023-08-28 |
| Adam Mindle | member of the Board | Appointed | 2023-08-28 |
| Mark Branson | member of the Board | Resigned | 2023-08-28 |
| Dean Medwid | Chief Executive Officer | Appointed | 2023-06-23 |
| Dominic Colvin | Chief Executive Officer ("CEO") | Resigned | 2023-06-23 |
Leadership
- Constantine Nkafu CEO, Board Member
- Dean Medwid CEO
- Gary Herick CFO
- John Cassels CFO
- Oliver Foeste CFO
- Andrew Steedman COO
- Adam Mindle Board Member
- Anthony Michael Panek Board Member
- Elliot Zemel Board Member